Drug treatment for Alzheimer's disease

被引:0
|
作者
Tom, T
机构
来源
WESTERN JOURNAL OF MEDICINE | 1998年 / 168卷 / 04期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:264 / 264
页数:1
相关论文
共 50 条
  • [21] Approach towards an integrative drug treatment of Alzheimer's disease
    Windisch, M
    ADVANCES IN DEMENTIA RESEARCH, 2000, : 301 - 313
  • [22] Approach towards an integrative drug treatment of Alzheimer's disease
    Windisch, M
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 2000, (59): : 301 - 313
  • [23] Prevalence of drug treatment in subjects with Alzheimer's disease in France
    Pariente, Antoine
    Helmer, Catherine
    Moore, Nicholas
    Fourrier, Annie
    Dartigues, Jean-Francois
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S156 - S157
  • [25] Ichfan - New antioxidant drug for the treatment of Alzheimer's disease
    Molotchkina, EM
    Ozerova, IB
    Burlakova, EBNM
    FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 : S229 - S230
  • [26] Nanoscale drug formulations for the treatment of Alzheimer's disease progression
    Liu, Liqin
    He, Haini
    Du, Bin
    He, Yang
    RSC ADVANCES, 2025, 15 (06) : 4031 - 4078
  • [27] Discovery of CNS drug candidates for treatment of Parkinson\'s disease and Alzheimer\'s disease
    Greenlee, William
    Stamford, Andrew
    Neustadt, Bernard
    Cumming, Jared
    Wyss, Daniel
    Wang, Allen Yu-Sen
    Strickland, Corey
    Voigt, Johannes
    Zhu, Johnny Zhaoning
    Lachowicz, Jean
    Kennedy, Matthew
    Parker, Eric
    Hunter, John
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [28] Administration of pre/probiotics with conventional drug treatment in Alzheimer's disease
    Hort, Jakub
    Valis, Martin
    Angelucci, Francesco
    NEURAL REGENERATION RESEARCH, 2020, 15 (03) : 448 - 449
  • [29] Ethical concerns in the use of palliative drug treatment for Alzheimer's disease
    Filley, CM
    Chapman, MM
    Dubovsky, SL
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 1996, 8 (02) : 202 - 205
  • [30] Cost-benefit evaluation of drug treatment for Alzheimer's disease
    Kanowski, S
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 1998, : 275 - 280